Literature DB >> 16759299

Global Guideline for Type 2 Diabetes: recommendations for standard, comprehensive, and minimal care.

.   

Abstract

The Clinical Guidelines Task Force of the International Diabetes Federation has created an evidence-based Global Guideline for the care of people with Type 2 diabetes around the world. The recommendations developed for three levels of care (standard, comprehensive, and minimal), which can be applied in settings with different resources, are presented here. The source document is published elsewhere.

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16759299     DOI： 10.1111/j.1464-5491.2006.01918.x

Source DB:  PubMed          Journal:  Diabet Med        ISSN： 0742-3071            Impact factor:   4.359


  139 in total

Review 1.  Initiating insulin in patients with type 2 diabetes.

Authors:  Adrian N C Lau; Terence Tang; Henry Halapy; Kevin Thorpe; Catherine H Y Yu
Journal:  CMAJ       Date:  2012-04-02       Impact factor: 8.262

2.  Electronegative low-density lipoprotein is associated with dense low-density lipoprotein in subjects with different levels of cardiovascular risk.

Authors:  Ana Paula de Queiroz Mello; Isis Tande da Silva; Aline Silva Oliveira; Valéria Sutti Nunes; Dulcineia Saes Parra Abdalla; Magnus Gidlund; Nágila Raquel Teixeira Damasceno
Journal:  Lipids       Date:  2010-06-24       Impact factor: 1.880

3.  Glucose self-monitoring: think twice for type 2 patients.

Authors:  Michael D Mendoza; John Hickner
Journal:  J Fam Pract       Date:  2008-11       Impact factor: 0.493

4.  Do diabetes-specialty clinics differ in management approach and outcome? A cross-sectional assessment of ambulatory type 2 diabetes patients in two teaching hospitals in Nigeria.

Authors:  Rasaq Adisa; Titilayo O Fakeye
Journal:  Ghana Med J       Date:  2016-06

5.  The effects of sulfonylureas plus metformin on lipids, blood pressure, and adverse events in type 2 diabetes: a meta-analysis of randomized controlled trials.

Authors:  Fan Zhang; Hao Xiang; Yunzhou Fan; Tsend-Ayush Ganchuluun; Wenhua Kong; Qian Ouyang; Jingwen Sun; Beibei Cao; Hongbo Jiang; Shaofa Nie
Journal:  Endocrine       Date:  2013-05-09       Impact factor: 3.633

6.  Characteristics of Registered Diabetics in Dhank Province in the Sultanate of Oman.

Authors:  Faisal Rabia Al-Rubaee; Moza Humaid Al-Abri
Journal:  Oman Med J       Date:  2016-05

7.  Liver-related Events in Human Immunodeficiency Virus-infected Persons With Occult Cirrhosis.

Authors:  Amine Benmassaoud; Roy Nitulescu; Thomas Pembroke; Alex S Halme; Peter Ghali; Marc Deschenes; Philip Wong; Marina B Klein; Giada Sebastiani
Journal:  Clin Infect Dis       Date:  2019-09-27       Impact factor: 9.079

8.  Rationale, design and baseline patient characteristics of the optimal type 2 diabetes management including benchmarking and standard treatment study in Greece.

Authors:  Michael S Kostapanos; Vasilis Tsimihodimos; Moses S Elisaf; Emmanouil Tzouvelekis; Nikos Nikas
Journal:  World J Diabetes       Date:  2014-02-15

9.  Role of age-related decrease of renal organic cation transporter 2 in the effect of atenolol on renal excretion of metformin in rats.

Authors:  Jiangxia Ren; Yan Zhou; Guoqiang Zhang; Liting Zhou; Jing Zhao; Yuhui Wei; Xin'an Wu
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2014-07-01       Impact factor: 2.441

10.  Switching from premixed insulin to glargine-based insulin regimen improves glycaemic control in patients with type 1 or type 2 diabetes: a retrospective primary-care-based analysis.

Authors:  Peter Sharplin; Jason Gordon; John R Peters; Anthony P Tetlow; Andrea J Longman; Philip McEwan
Journal:  Cardiovasc Diabetol       Date:  2009-02-16       Impact factor: 9.951
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.